🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 10 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 04/08/2000 | 51,19 | 52,73 | 50,75 | 51,89 | +2,75% | 3,88% | 335.000 |
| 03/08/2000 | 51,00 | 52,22 | 49,16 | 50,50 | -3,81% | 6,00% | 555.200 |
| 02/08/2000 | 52,00 | 52,56 | 50,19 | 52,50 | -1,18% | 4,57% | 289.200 |
| 01/08/2000 | 49,00 | 53,63 | 47,26 | 53,13 | +8,42% | 12,99% | 447.600 |
| 31/07/2000 | 49,69 | 49,69 | 44,31 | 49,00 | -1,01% | 10,82% | 489.400 |
| 28/07/2000 | 51,23 | 51,23 | 49,00 | 49,50 | -4,00% | 4,36% | 955.000 |
| 27/07/2000 | 54,75 | 55,00 | 50,50 | 51,56 | -2,37% | 8,22% | 577.800 |
| 26/07/2000 | 53,00 | 57,06 | 50,00 | 52,81 | +1,99% | 13,33% | 865.000 |
| 25/07/2000 | 54,50 | 55,00 | 51,69 | 51,78 | -7,22% | 6,08% | 401.200 |
| 24/07/2000 | 57,25 | 59,00 | 55,00 | 55,81 | -2,93% | 6,99% | 130.600 |
| 21/07/2000 | 57,75 | 59,75 | 55,81 | 57,50 | +0,00% | 6,82% | 129.600 |
| 20/07/2000 | 56,38 | 58,13 | 56,00 | 57,50 | +2,00% | 3,77% | 408.400 |
| 19/07/2000 | 59,75 | 60,00 | 56,00 | 56,38 | -6,04% | 6,69% | 632.000 |
| 18/07/2000 | 59,06 | 61,50 | 59,06 | 60,00 | -0,05% | 4,13% | 275.000 |
| 17/07/2000 | 56,27 | 62,00 | 56,00 | 60,03 | +4,35% | 10,66% | 247.200 |
| 14/07/2000 | 58,13 | 59,63 | 55,31 | 57,53 | -7,58% | 7,42% | 1.755.000 |
| 13/07/2000 | 64,38 | 65,50 | 61,52 | 62,25 | -3,11% | 6,19% | 968.400 |
| 12/07/2000 | 60,63 | 66,00 | 60,44 | 64,25 | +5,33% | 9,18% | 819.800 |
| 11/07/2000 | 57,25 | 63,13 | 57,25 | 61,00 | +4,83% | 10,26% | 715.400 |
| 10/07/2000 | 55,50 | 58,50 | 54,66 | 58,19 | +3,22% | 6,93% | 398.600 |
| 07/07/2000 | 58,26 | 58,44 | 54,75 | 56,38 | -4,35% | 6,33% | 538.600 |
| 06/07/2000 | 51,13 | 59,25 | 51,00 | 58,94 | +14,72% | 16,14% | 1.154.000 |
| 05/07/2000 | 45,25 | 52,38 | 45,00 | 51,38 | -2,14% | 16,30% | 508.400 |
| 03/07/2000 | 54,13 | 54,13 | 51,78 | 52,50 | -3,11% | 4,33% | 370.000 |
| 30/06/2000 | 57,52 | 57,53 | 52,50 | 54,19 | -0,91% | 8,75% | 1.687.800 |
| 29/06/2000 | 48,88 | 59,88 | 48,88 | 54,69 | +9,44% | 22,51% | 2.035.600 |
| 28/06/2000 | 47,31 | 50,00 | 46,75 | 49,97 | +2,30% | 6,87% | 888.600 |
| 27/06/2000 | 46,00 | 50,00 | 46,00 | 48,84 | +8,54% | 8,70% | 949.800 |
| 26/06/2000 | 42,00 | 45,06 | 42,00 | 45,00 | +6,04% | 7,29% | 236.400 |
| 23/06/2000 | 42,00 | 42,56 | 41,75 | 42,44 | +0,44% | 1,93% | 463.400 |